NeuroSearch's core business covers the development of novel drugs, based on a broad and well-established drug discovery platform focusing on ion channels and central nervous system (CNS) disorders.
We have significant preclinical and clinical development experience, and our drug discovery platforms have been utilised by a number of large international pharmaceutical companies with whom we have collaborated. Our pipeline comprises several advanced clinical and preclinical drug candidates in the field of psychiatry and neurology and other major indications.
